NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 25 filers reported holding NEUROPACE INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $720 | -28.1% | 74 | -66.8% | 0.00% | – |
| Q2 2023 | $1,002 | -1.4% | 223 | +1.8% | 0.00% | – |
| Q1 2023 | $1,016 | +905.9% | 219 | +222.1% | 0.00% | – |
| Q4 2022 | $101 | – | 68 | -20.9% | 0.00% | – |
| Q3 2022 | $0 | – | 86 | +100.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 43 | -97.3% | 0.00% | – |
| Q1 2022 | $13,000 | -68.3% | 1,596 | -60.8% | 0.00% | – |
| Q4 2021 | $41,000 | -74.5% | 4,071 | -60.0% | 0.00% | – |
| Q3 2021 | $161,000 | -33.7% | 10,179 | -0.4% | 0.00% | – |
| Q2 2021 | $243,000 | – | 10,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KCK LTD. | 5,621,111 | $27,824,000 | 39.09% |
| Revelation Capital Management, LLC | 248,127 | $1,228,000 | 17.38% |
| Soleus Capital Management, L.P. | 2,334,003 | $11,553,000 | 1.80% |
| Orbimed Advisors | 4,012,281 | $19,861,000 | 0.36% |
| Opaleye Management Inc. | 90,100 | $446,000 | 0.20% |
| Nantahala Capital Management | 478,438 | $2,368,000 | 0.12% |
| Bellevue Group AG | 507,930 | $2,514,000 | 0.04% |
| Ergoteles LLC | 34,800 | $172,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 26,148 | $129,000 | 0.00% |
| Point72 Asset Management, L.P. | 149,199 | $739,000 | 0.00% |